Related references
Note: Only part of the references are listed.Isotype-specific inhibitors of the glycolytic keyregulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation
Gilles A. Spoden et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Causes and consequences of increased glucose metabolism of cancers
Robert J. Gillies et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet
Jeremy Marsh et al.
NUTRITION & METABOLISM (2008)
Therapeutic Starvation and Autophagy in Prostate Cancer: A New Paradigm for Targeting Metabolism in Cancer Therapy
Robert S. DiPaola et al.
PROSTATE (2008)
Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation
Metin Kurtoglu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy
Jason L. J. Dearling et al.
CLINICAL CANCER RESEARCH (2007)
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia
Xianhua Cao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
2-Deoxy-D-glucose combined with cisplatin, enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells
Andreart L. Simons et al.
CANCER RESEARCH (2007)
Cancer's molecular sweet tooth and the Warburg effect
Jung-whan Kim et al.
CANCER RESEARCH (2006)
Altered gene expression induced by ionizing radiation and glycolytic inhibitor 2-deoxy-glucose in a human glioma cell line - Implications for radiosensitization
Katherine Heminger et al.
CANCER BIOLOGY & THERAPY (2006)
Optimizing cancer radiotherapy with 2-deoxy-D-glucose - Dose escalation studies in patients with glioblastoma multiforme
DH Singh et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2005)
Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor β signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model
L Xu et al.
CANCER RESEARCH (2005)
Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells
R Varshney et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2005)
2-deoxy-D-glucose enhances the cytotoxicity of topoisomerase inhibitors in human tumor cell lines
BS Dwarukanath et al.
CANCER BIOLOGY & THERAPY (2004)
Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-D-glucose and 6-aminonicotinamide
R Varshney et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2004)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors
S Di Cosimo et al.
DRUGS OF TODAY (2003)
Molecular imaging of cancer with positron emission tomography
SS Gambhir
NATURE REVIEWS CANCER (2002)
Share Paper
